The increase in the cystatin F dimer level in plasma from patients with AD patients was closely correlated with the Aβ level and clinical mental score of patients with AD, suggesting that the cystatin F dimer level in plasma from patients with AD might be useful for assessing AD severity. Here, CST7 is linked to Alzheimer disease.